These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 1652865)

  • 1. [The synthetic peptide 62-75 VP3 of the hepatitis A virus induces virus-binding antibodies].
    Kusov IuIu; Kazachkov IuA; Dzagurov GK; Nastashenko TA; Kozhich AT; Gabrielian AE; Chikin LD; Ivanov VT; Balaian MS
    Vopr Virusol; 1991; 36(2):114-7. PubMed ID: 1652865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antigenic epitopes of the hepatitis A virus polyprotein.
    Khudyakov YE; Lopareva EN; Jue DL; Fang S; Spelbring J; Krawczynski K; Margolis HS; Fields HA
    Virology; 1999 Aug; 260(2):260-72. PubMed ID: 10417261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conformational constraints of conserved neutralizing epitopes from a major antigenic area of human respiratory syncytial virus fusion glycoprotein.
    López JA; Andreu D; Carreño C; Whyte P; Taylor G; Melero JA
    J Gen Virol; 1993 Dec; 74 ( Pt 12)():2567-77. PubMed ID: 7506298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Mapping of the structural proteins of the hepatitis A virus].
    Kusov IuIu; Kazachkov IuA; Dzagurov GK; Nastashenko TA; Balaian MS; Kozhich AT
    Vopr Virusol; 1990; 35(6):468-71. PubMed ID: 1964513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancement of the immunogenicity of a synthetic peptide bearing a VP3 epitope of hepatitis A virus.
    Pintó RM; González-Dankaart JF; Sánchez G; Guix S; Gómara MJ; García M; Haro I; Bosch A
    FEBS Lett; 1998 Oct; 438(1-2):106-10. PubMed ID: 9821968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoreactivity of human and rabbit antisera to hepatitis A virus.
    Gauss-Müller V; Deinhardt F
    J Med Virol; 1988 Feb; 24(2):219-28. PubMed ID: 2832540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthetic peptides against foot-and-mouth disease--immunization with VP1-peptides of type O1-Kaufbeuren.
    Liebermann H; Holl U; Reimann I; Nöckler A; Schäfer D; Thalmann G; Dölling R
    Arch Exp Veterinarmed; 1990; 44(6):883-90. PubMed ID: 1966360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding of neutralizing monoclonal antibodies to regions of the fusion protein of respiratory syncytial virus expressed in Escherichia coli.
    Lounsbach GR; Bourgeois C; West WH; Robinson JW; Carter MJ; Toms GL
    J Gen Virol; 1993 Dec; 74 ( Pt 12)():2559-65. PubMed ID: 7506297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mimicry of the immunodominant conformation-dependent antigenic site of hepatitis A virus by motifs selected from synthetic peptide libraries.
    Mattioli S; Imberti L; Stellini R; Primi D
    J Virol; 1995 Sep; 69(9):5294-9. PubMed ID: 7543581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure of the hepatitis A virion: peptide mapping of the capsid region.
    Wheeler CM; Robertson BH; Van Nest G; Dina D; Bradley DW; Fields HA
    J Virol; 1986 May; 58(2):307-13. PubMed ID: 3009847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of anti-peptide and anti-protein sera. Effect of peptide presentation on immunogenicity.
    McLean GW; Owsianka AM; Subak-Sharpe JH; Marsden HS
    J Immunol Methods; 1991 Mar; 137(2):149-57. PubMed ID: 1707429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypervariable epitope constructs representing variability in envelope glycoprotein of SIV induce a broad humoral immune response in rabbits and rhesus macaques.
    Meyer D; Anderson DE; Gardner MB; Torres JV
    AIDS Res Hum Retroviruses; 1998 Jun; 14(9):751-60. PubMed ID: 9643375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-hepatitis A virus antibody response elicited in mice by different forms of a synthetic VP1 peptide.
    Haro I; Pinto RM; Gonzalez-Dankaart JF; Perez JA; Reig F; Bosch A
    Microbiol Immunol; 1995; 39(7):485-90. PubMed ID: 8569533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant proteins VP1 and VP3 of hepatitis A virus prime for neutralizing response.
    Gauss-Müller V; Zhou MQ; von der Helm K; Deinhardt F
    J Med Virol; 1990 Aug; 31(4):277-83. PubMed ID: 2176673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Virus neutralizing and enhancing epitopes characterized by synthetic oligopeptides derived from the feline leukaemia virus glycoprotein sequence.
    Nick S; Klaws J; Friebel K; Birr C; Hunsmann G; Bayer H
    J Gen Virol; 1990 Jan; 71 ( Pt 1)():77-83. PubMed ID: 1689371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemically synthesized peptides elicit neutralizing antibody to bovine enterovirus.
    Smyth MS; Hoey EM; Trudgett A; Martin SJ; Brown F
    J Gen Virol; 1990 Jan; 71 ( Pt 1)():231-4. PubMed ID: 1689368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Equine arteritis virus-neutralizing antibody in the horse is induced by a determinant on the large envelope glycoprotein GL.
    Chirnside ED; de Vries AA; Mumford JA; Rottier PJ
    J Gen Virol; 1995 Aug; 76 ( Pt 8)():1989-98. PubMed ID: 7636479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A synthetic peptide corresponding to the cleavage region of VP3 from rotavirus SA11 induces neutralizing antibodies.
    Streckert HJ; Brüssow H; Werchau H
    J Virol; 1988 Nov; 62(11):4265-9. PubMed ID: 2845138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of amino acids located in the antibody binding sites of human hepatitis A virus.
    Nainan OV; Brinton MA; Margolis HS
    Virology; 1992 Dec; 191(2):984-7. PubMed ID: 1280386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Synthesis and immunochemical properties of oligopeptides--fragments of capsid proteins of the hepatitis A virus].
    Chikin LD; Kozhich AT; Ivanov VS; Ivanov VT; Nastashenko TA; Kusov IuIu; Balaian MS
    Bioorg Khim; 1991 Jul; 17(7):964-72. PubMed ID: 1724368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.